IS7245A - Aðferð til að hvarfa lýtinga og notkun á hvarfafurðum við framleiðslu lyfja - Google Patents

Aðferð til að hvarfa lýtinga og notkun á hvarfafurðum við framleiðslu lyfja

Info

Publication number: IS7245A
Authority: IS; Iceland
Prior art keywords: lithiums; pharmaceuticals; reacting; manufacture; reaction products
Prior art date: 2001-11-15

Application number

IS7245A

Other languages

English (en)

Other versions

IS2812B (is

Inventor

Nowicky Wassyl

Original Assignee

Nowicky Wassyl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-15

Filing date

2004-04-30

Publication date

2004-04-30

2004-04-30 Application filed by Nowicky Wassyl filed Critical Nowicky Wassyl

2004-04-30 Publication of IS7245A publication Critical patent/IS7245A/is

2012-11-15 Publication of IS2812B publication Critical patent/IS2812B/is

Links

239000007795 chemical reaction product Substances 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G5/00—Alkaloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Immunology (AREA)
Obesity (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Oncology (AREA)
Virology (AREA)
Dermatology (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS7245A 2001-11-15 2004-04-30 Aðferð til að hvarfa lýtinga og notkun á hvarfafurðum við framleiðslu lyfja IS2812B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH02094/01A CH695417A5 (de)	2001-11-15	2001-11-15	Verfahren zur Umsetzung von Alkaloiden.
PCT/EP2002/012003 WO2003041721A1 (en)	2001-11-15	2002-10-28	Process for reacting alkaloids and use of the reaction products in the preparation of medicaments

Publications (2)

Publication Number	Publication Date
IS7245A true IS7245A (is)	2004-04-30
IS2812B IS2812B (is)	2012-11-15

Family

ID=4567486

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7245A IS2812B (is)	2001-11-15	2004-04-30	Aðferð til að hvarfa lýtinga og notkun á hvarfafurðum við framleiðslu lyfja

Country Status (38)

Country	Link
US (1)	US20050043340A1 (is)
EP (1)	EP1443943B1 (is)
JP (1)	JP2005509006A (is)
KR (1)	KR100849488B1 (is)
CN (1)	CN100436462C (is)
AR (1)	AR037527A1 (is)
AT (1)	ATE485826T1 (is)
AU (1)	AU2002346888B2 (is)
BR (1)	BR0214173A (is)
CA (1)	CA2465723C (is)
CH (1)	CH695417A5 (is)
CO (1)	CO5580784A2 (is)
CR (1)	CR7340A (is)
CU (1)	CU23451B7 (is)
CY (1)	CY1111139T1 (is)
DE (1)	DE60238134D1 (is)
DK (1)	DK1443943T3 (is)
EA (1)	EA007097B1 (is)
EC (1)	ECSP045107A (is)
ES (1)	ES2353207T3 (is)
GE (1)	GEP20053701B (is)
HR (1)	HRP20040430A2 (is)
HU (1)	HU229688B1 (is)
IL (2)	IL161766A0 (is)
IS (1)	IS2812B (is)
MA (1)	MA26232A1 (is)
MX (1)	MXPA04004643A (is)
NO (1)	NO334701B1 (is)
NZ (1)	NZ532941A (is)
PL (1)	PL212111B1 (is)
PT (1)	PT1443943E (is)
RS (1)	RS51219B (is)
SA (1)	SA02230496B1 (is)
TN (1)	TNSN04084A1 (is)
TW (1)	TWI262080B (is)
UA (1)	UA76535C2 (is)
WO (1)	WO2003041721A1 (is)
ZA (1)	ZA200403371B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1459753A1 (en)	2003-03-18	2004-09-22	Nowicky, Wassyl, Dipl.-Ing. DDr.	Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2006053680A1 (en) *	2004-11-19	2006-05-26	Nowicky Wassili	Ex vivo cancer diagnostic method
WO2006053649A1 (en) *	2004-11-19	2006-05-26	Nowicky Wassili	Method for the detection of cancer
WO2007073919A2 (en)	2005-12-28	2007-07-05	Nowicky Wassili	Method and kit for the detection of cancer
ITMI20080284A1 (it) *	2008-02-22	2009-08-23	Indena Spa	Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
CA2941315C (en) *	2016-08-12	2018-03-06	Api Labs Inc.	High thebaine poppy and methods of producing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3865830A (en) *	1969-06-16	1975-02-11	Nikolai Mikhailovich Turkevich	Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof
SU368254A1 (ru)	1969-06-16	1973-01-26	А. И. Потопальский , В. М. Новицкий Львовский государственный медицинский институт	Способ получения соединений тиофосфамида с алкалоидами чистотела большого
AT354644B (de) *	1975-12-19	1980-01-25	Nowicky Wassili	Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure
AT377988B (de) *	1976-06-28	1985-05-28	Nowicky Wassili	Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
DE3128018A1 (de)	1981-07-13	1983-04-07	Wassyl 1060 Wien Nowicky	"verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) *	1982-05-18	1990-11-13	Nowicky Wassili	Method of treating human illnesses which compromise the ability to mount an effective immunological response
AT407608B (de) *	1994-03-18	2001-05-25	Nowicky Wassili	Mittel zur behandlung von osteoporose
AT407833B (de) *	1995-06-01	2001-06-25	Nowicky Wassyl Dr	Mittel zur behandlung von strahlenschäden
AT408719B (de) *	2000-03-22	2002-02-25	Nowicky Wassili	Mittel zur behandlung von hepatitis c

2001
- 2001-11-15 CH CH02094/01A patent/CH695417A5/de not_active IP Right Cessation
2002
- 2002-10-25 TW TW091125317A patent/TWI262080B/zh not_active IP Right Cessation
- 2002-10-28 DE DE60238134T patent/DE60238134D1/de not_active Expired - Lifetime
- 2002-10-28 KR KR1020047007480A patent/KR100849488B1/ko not_active Expired - Fee Related
- 2002-10-28 EA EA200400679A patent/EA007097B1/ru not_active IP Right Cessation
- 2002-10-28 ES ES02783017T patent/ES2353207T3/es not_active Expired - Lifetime
- 2002-10-28 PT PT02783017T patent/PT1443943E/pt unknown
- 2002-10-28 GE GE8206A patent/GEP20053701B/en unknown
- 2002-10-28 HU HU0402365A patent/HU229688B1/hu unknown
- 2002-10-28 NZ NZ532941A patent/NZ532941A/en not_active IP Right Cessation
- 2002-10-28 AT AT02783017T patent/ATE485826T1/de active
- 2002-10-28 JP JP2003543608A patent/JP2005509006A/ja active Pending
- 2002-10-28 BR BR0214173-6A patent/BR0214173A/pt not_active IP Right Cessation
- 2002-10-28 US US10/495,729 patent/US20050043340A1/en not_active Abandoned
- 2002-10-28 RS YUP-408/04A patent/RS51219B/sr unknown
- 2002-10-28 WO PCT/EP2002/012003 patent/WO2003041721A1/en not_active Ceased
- 2002-10-28 HR HR20040430A patent/HRP20040430A2/hr not_active IP Right Cessation
- 2002-10-28 MX MXPA04004643A patent/MXPA04004643A/es active IP Right Grant
- 2002-10-28 UA UA20040604558A patent/UA76535C2/uk unknown
- 2002-10-28 PL PL368879A patent/PL212111B1/pl unknown
- 2002-10-28 EP EP02783017A patent/EP1443943B1/en not_active Expired - Lifetime
- 2002-10-28 DK DK02783017.3T patent/DK1443943T3/da active
- 2002-10-28 IL IL16176602A patent/IL161766A0/xx unknown
- 2002-10-28 AU AU2002346888A patent/AU2002346888B2/en not_active Ceased
- 2002-10-28 CA CA002465723A patent/CA2465723C/en not_active Expired - Fee Related
- 2002-11-15 CN CNB021513384A patent/CN100436462C/zh not_active Expired - Fee Related
- 2002-11-15 AR ARP020104397A patent/AR037527A1/es unknown
- 2002-12-30 SA SA02230496A patent/SA02230496B1/ar unknown
2004
- 2004-04-30 IS IS7245A patent/IS2812B/is unknown
- 2004-05-04 ZA ZA200403371A patent/ZA200403371B/en unknown
- 2004-05-04 IL IL161766A patent/IL161766A/en not_active IP Right Cessation
- 2004-05-05 NO NO20041845A patent/NO334701B1/no not_active IP Right Cessation
- 2004-05-11 CR CR7340A patent/CR7340A/es unknown
- 2004-05-13 TN TNP2004000084A patent/TNSN04084A1/en unknown
- 2004-05-14 EC EC2004005107A patent/ECSP045107A/es unknown
- 2004-05-14 MA MA27679A patent/MA26232A1/fr unknown
- 2004-05-17 CU CU20040105A patent/CU23451B7/es not_active IP Right Cessation
- 2004-06-01 CO CO04051024A patent/CO5580784A2/es not_active Application Discontinuation
2011
- 2011-01-24 CY CY20111100077T patent/CY1111139T1/el unknown

Also Published As

Publication number	Publication date
MA26232A1 (fr)	2004-07-01
CO5580784A2 (es)	2005-11-30
ECSP045107A (es)	2004-06-28
MXPA04004643A (es)	2005-03-14
CR7340A (es)	2004-12-06
NO20041845D0 (no)	2004-05-05
WO2003041721A1 (en)	2003-05-22
HUP0402365A2 (hu)	2005-02-28
KR100849488B1 (ko)	2008-07-31
UA76535C2 (en)	2006-08-15
ATE485826T1 (de)	2010-11-15
SA02230496B1 (ar)	2008-09-10
JP2005509006A (ja)	2005-04-07
RS40804A (sr)	2006-12-15
DK1443943T3 (da)	2011-02-14
EP1443943A1 (en)	2004-08-11
IL161766A (en)	2009-11-18
US20050043340A1 (en)	2005-02-24
AU2002346888B2 (en)	2007-03-22
CU23451B7 (es)	2009-10-16
TWI262080B (en)	2006-09-21
RS51219B (sr)	2010-12-31
NO20041845L (no)	2004-06-25
EP1443943B1 (en)	2010-10-27
NO334701B1 (no)	2014-05-12
HRP20040430B1 (is)	2012-11-30
PL368879A1 (en)	2005-04-04
ZA200403371B (en)	2005-05-04
CY1111139T1 (el)	2015-06-11
CA2465723C (en)	2010-01-05
TNSN04084A1 (en)	2006-06-01
HRP20040430A2 (en)	2004-08-31
HK1054041A1 (zh)	2003-11-14
IL161766A0 (en)	2005-11-20
AR037527A1 (es)	2004-11-17
CN100436462C (zh)	2008-11-26
DE60238134D1 (de)	2010-12-09
PL212111B1 (pl)	2012-08-31
PT1443943E (pt)	2010-12-03
HU229688B1 (en)	2014-04-28
KR20050040859A (ko)	2005-05-03
GEP20053701B (en)	2005-12-12
BR0214173A (pt)	2004-09-28
AU2002346888C1 (en)	2003-05-26
EA007097B1 (ru)	2006-06-30
IS2812B (is)	2012-11-15
ES2353207T3 (es)	2011-02-28
NZ532941A (en)	2006-08-31
CA2465723A1 (en)	2003-05-22
CH695417A5 (de)	2006-05-15
CN1422859A (zh)	2003-06-11
EA200400679A1 (ru)	2004-10-28

Publication	Publication Date	Title
NO20031776D0 (no)	2003-04-16	Null-boringskomplettering og produksjonssystem
DK1436309T3 (da)	2013-01-02	BGL3-beta-glukosidase og nukleinsyrer kodende derfor
IS2513B (is)	2009-05-15	Búnaður til að framleiða óson og aðferð til framleiðslu á ósoni
DK1511790T3 (da)	2013-09-02	Polyaminosyrer funktionaliseret med alfa-tocopherol og anvendelser deraf, især til terapeutiske applikationer
NO20052860D0 (no)	2005-06-13	Farmasoytiske pelletter omfattende tamsulosin og en fremgangsmate for fremstilling av samme
IS7369A (is)	2004-07-23	Aðferð og tæki til örflögunýmyndunar
IS7090A (is)	2003-12-22	Kerfi,aðferð og tölvuhugbúnaður til að forma og kaupa lækningatæki
DK2423335T3 (da)	2014-08-18	Kimæriske immunmodulatoriske forbindelser og fremgangsmåder til anvendelse deraf
DK1206495T3 (da)	2007-06-11	Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser deraf
NO20040894L (no)	2004-03-01	Fremgangsmate for fremstilling av klorsyrling og klordioksid
DK1641822T3 (da)	2013-07-22	Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
IS6724A (is)	2003-02-20	Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra
NO20033587L (no)	2003-10-13	Fremgangsmåte og innretning for fremstilling av mineralull og mineralullprodukter
DK1554315T3 (da)	2011-07-04	Vandopløslige jern-kulhydrat-komplekser, fremsilling deraf og lægemidler, der indeholder disse
DK1516053T3 (da)	2013-03-25	Xylanaser, nucleinsyrer, som koder herfor, og fremgangsmåder til at fremstille og benytte disse
NO20031775D0 (no)	2003-04-16	Oppblåsbar pakning og fremgangsmåte
DK0969694T3 (da)	2007-05-14	Tryktransducer og fremgangsmåde til fremstilling heraf
NO20042694L (no)	2004-07-22	17 alfa-alkyl-17 beta-oksy-ostratriener og mellomprodukter for fremstilling av disse, anvendelse av 17 alfa-alkyl-17 beta-oksy-ostratrienene til fremstilling av legemidler samt farmasoytiske preparater
AU2003234113A8 (en)	2003-11-03	Portable sales assistant terminal system
IS7594A (is)	2004-12-13	Laxófoxifen tafla og húðun hennar
IS2290B (is)	2007-10-15	Aðferð til framleiðslu á díhýdroxýesterum og afleiðum þeirra
DK1281721T3 (da)	2007-09-24	Termisk konverterede stivelser og fremgangsmåde til fremstilling heraf
NO20021001D0 (no)	2002-02-28	Radiofarmasöytiske produkter og fremstilling derav
NO20015399L (no)	2001-11-05	System og fremgangsmåte for produktdemontering
IS7239A (is)	2004-04-29	Aðferð til framleiðslu á essítalóprami